Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Reopening of long-term care facilities is ‘an absolute necessity for our well-being’

For nearly a year, nursing homes and assisted living centers have been mostly closed to visitors. Now, it's time for them to open back up and relieve residents of crushing isolation, according to a growing chorus of long-term care experts, caregivers, consumer groups and physicians.

4 Mar 2021

UTHSC researchers awarded $1.9 million to study white matter mechanisms underlying dementia

The National Institute of Neurological Disorders and Stroke has awarded two UTHSC researchers over $1.9 million to study the pathogenesis of white matter damage, a main contributing factor to dementia.

3 Mar 2021

Researchers identify drug target to fight Parkinson’s and Alzheimer’s disease

Neurodegenerative disorders such as Parkinson's and Alzheimer's disease are in the firing line after researchers identified an attractive therapeutic drug target.

3 Mar 2021

$High-resolution imaging, 3D computer modeling reveal the fractal nature of neurons$

High-resolution imaging, 3D computer modeling reveal the fractal nature of neurons

High-resolution imaging and 3D computer modeling show that the dendrites of neurons weave through space in a way that balances their need to connect to other neurons with the costs of doing so.

3 Mar 2021

Novel drug for preventing Alzheimer's disease found to be safe and effective in animals

Researchers at the University of California San Diego School of Medicine and Massachusetts General Hospital have identified a new drug that could prevent Alzheimer's disease by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques in the brain.

2 Mar 2021

New drug could prevent Alzheimer's by modulating key enzyme involved in amyloid plaque formation

Amyloid plaques are pathological hallmarks of Alzheimer's disease (AD) -- clumps of misfolded proteins that accumulate in the brain, disrupting and killing neurons and resulting in the progressive cognitive impairment that is characteristic of the widespread neurological disorder.

2 Mar 2021

Deep learning-based splice-AI can help predict the onset of Alzheimer's disease

Korea Brain Research Institute (KBRI, President Suh Pann-ghill) announced that the research team led by Dr. Jae-Yeol Joo discovered new cryptic splice variants and SNVs in PLCg1 gene of AD-specific models for the first time using Splice-AI.

1 Mar 2021

Aerobic exercise may help slow memory loss for older adults with Alzheimer's dementia

Promising new research shows aerobic exercise may help slow memory loss for older adults living with Alzheimer's dementia.

27 Feb 2021

Study demonstrates the novel agonistic effect of curcumin on lipid transcription

Curcumin is a polyphenol compound produced by plants of the Curcuma longa species and has been reported to have many physiological activities, which include anti-oxidation, anti-inflammatory, anti-cancer, and anti-amyloid properties.

27 Feb 2021

Study: Heart problems cause disturbed gene activity in the brain's memory center

Heart problems cause disturbed gene activity in the brain's memory center, from which cognitive deficits arise.

27 Feb 2021

Well-known spasmolytic drug can suppress inflammatory response in astrocytes

Biologists from RUDN University confirmed that a well-known spasmolytic drug called hymecromone can suppress the inflammatory response in astrocytes, important glial cells of the central nervous system.

26 Feb 2021

Study finds novel way to diagnose Alzheimer's disease before symptoms occur

Early diagnosis of Alzheimer's disease has been shown to reduce cost and improve patient outcomes, but current diagnostic approaches can be invasive and costly.

26 Feb 2021

Nanobowls show potential for diagnostics and treatment of Alzheimer's

Scientists are still a long way from being able to treat Alzheimer's Disease, in part because the protein aggregates that can become brain plaques, a hallmark of the disease, are hard to study.

26 Feb 2021

Study explores impact of reminiscence therapy on Alzheimer’s and dementia patients

The RRF Foundation for Aging awarded a multidisciplinary team from The University of Texas at Arlington with more than $160,000 for a project that explores the impact of reminiscence therapy and creation of digital memoirs on those diagnosed with Alzheimer's disease and related dementia.

25 Feb 2021

Alzheimer's Disease News and Research

Further Reading

Reopening of long-term care facilities is ‘an absolute necessity for our well-being’

UTHSC researchers awarded $1.9 million to study white matter mechanisms underlying dementia

Researchers identify drug target to fight Parkinson’s and Alzheimer’s disease

High-resolution imaging, 3D computer modeling reveal the fractal nature of neurons

Novel drug for preventing Alzheimer's disease found to be safe and effective in animals

New drug could prevent Alzheimer's by modulating key enzyme involved in amyloid plaque formation

Deep learning-based splice-AI can help predict the onset of Alzheimer's disease

Aerobic exercise may help slow memory loss for older adults with Alzheimer's dementia

Study demonstrates the novel agonistic effect of curcumin on lipid transcription

Study: Heart problems cause disturbed gene activity in the brain's memory center

Well-known spasmolytic drug can suppress inflammatory response in astrocytes

Study finds novel way to diagnose Alzheimer's disease before symptoms occur

Nanobowls show potential for diagnostics and treatment of Alzheimer's

Study explores impact of reminiscence therapy on Alzheimer’s and dementia patients

Study shows direct connection between the gut microbiome and Alzheimer's-like behavior

Researchers probe deeper into the neuronal mechanisms underlying olfactory dysfunction in Alzheimer’s

Preventing seizures after head injury could slow or prevent the onset of dementia

Study identifies how military blast exposures affect the brain, increase risk of Alzheimer's

New biomarker could help identify people at risk of Alzheimer's disease

Researchers discover a mechanism linked to stem cell aging

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News